PTC Inc. PTC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +12.24%
- 1 year
- -0.93%
- Open
- 194.86
- Prev close
- 194.80
- Mkt cap
- 21.24B
- Vol
- 1.58M
- Avg vol
- 2.41M
- EPS
- 10.31
- P/E
- 18.97
- Div yield
- 0.00%
More statistics
- Low
- 194.10
- High
- 195.71
- Forward P/E
- 21.93
- Beta
- 0.99
- Short ratio
- 1.19
- Inst. own
- 108.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 162.09
- 200-d avg
- 146.95
- 1y target
- 201.00
5D chart
Signals (127)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:50 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 1 day ago |
| RSI: Overbought | Oct 30, 3:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:40 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 2:35 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:50 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:45 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:30 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:25 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:20 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:50 AM | 2 days ago |
| RSI: Overbought | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:10 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:10 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| RSI: Overbought | Oct 26, 3:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:20 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
News
1 day ago prnewswire.com
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., Oct. 30, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 28, 2026, the company approved non-statutory stock options to purchase an aggregate of…
2 days ago globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)
BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
2 days ago globenewswire.com
Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
Interim Results in Super-Aged Rats Tested Externally Show Preserved Motor Performance and Reduced Fat Mass, Consistent with Prior Findings in Aged Mice Tested at Eos's R&D Facility; Data Support…
2 days ago marketbeat.com
PTC Therapeutics Q3 Earnings Call Highlights
PTC Therapeutics NASDAQ: PTCT reported third-quarter 2026 total revenue of $358 million, including $276 million in net product revenue, as sales of phenylketonuria treatment Sephience continued to…
2 days ago prnewswire.com
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
– Strong Q3 2026 performance with total revenue of $358 million, including $276 million of product revenue – – Full-year 2026 expected total revenue increased to $1.29 to $1.32 billion, with…
3 days ago seekingalpha.com
Parnassus Mid Cap Growth Fund: Q3 2026 Performance Review
The portfolio's outperformance was primarily driven by our holdings in the Health Care sector, which delivered strong returns for the quarter on company-specific catalysts. Information Technology…
4 days ago zacks.com
Analysts Estimate PTC Inc. (PTC) to Report a Decline in Earnings: What to Look Out for
PTC Inc. (PTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
1 week ago globenewswire.com
Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142)…
1 week ago prnewswire.com
PTC Launches PTC Jetstream to Make Enterprise Collaboration a Connected Part of the Product Development Lifecycle
Brings internal teams, suppliers, and partners into secure Rooms to review 2D and 3D product content in the browser Keeps comments, markups, versions, and decisions in context to accelerate reviews…
1 week ago benzinga.com
Top 3 Tech Stocks That May Keep You Up At Night This Month
Accenture, Atlassian and PTC show overbought momentum signals, with RSI readings of 76.1, 72.1 and 79 after strong recent gains.
1 week ago prnewswire.com
PTC to Announce Fourth Fiscal Quarter and Full Year 2026 Results on Wednesday, November 4, 2026
BOSTON, Oct. 19, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) will release its fiscal 2026 fourth quarter and full year results on Wednesday, November 4th after the stock market closes. As previously…
2 weeks ago prnewswire.com
PTC Announces Servigistics Renewal with U.S. Air Force
Optimizes service parts across complex global supply network Transforms planning productivity through exception-based management AI-powered intelligence built on deep service supply chain expertise…
2 weeks ago prnewswire.com
PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
WARREN, N.J., Oct. 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2026 financial…
2 weeks ago gurufocus.com
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene
2 weeks ago prnewswire.com
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
3 weeks ago marketbeat.com
Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
Schneider Electric OTCMKTS: SBGSY just made the biggest bet in its history. On Oct. 5, the French energy management giant agreed to buy PTC NASDAQ: PTC for about $22.6 billion in cash.
3 weeks ago benzinga.com
Treasury Yields Reach 24-Year Highs, Telecom Stocks Sell Off: This Week On Wall Street
S&P 500 tops 7,800 as Treasury yields hit 24-year highs. AT&T, Verizon and T-Mobile sank thanks to SpaceX. Bank earnings and CPI are next.
3 weeks ago globenewswire.com
Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
3 weeks ago prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of PTC Inc. (NASDAQ: PTC)
NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
-
3 weeks ago benzinga.com
Citigroup Maintains Neutral on PTC, Raises Price Target to $205
Citigroup analyst Tyler Radke maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $141 to $205.
3 weeks ago gurufocus.com
PTC Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PTC Inc. - PTC
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
-
3 weeks ago benzinga.com
JP Morgan Upgrades PTC to Neutral, Raises Price Target to $205
JP Morgan analyst Alexei Gogolev upgrades PTC (NASDAQ:PTC) from Underweight to Neutral and raises the price target from $145 to $205.
3 weeks ago businesswire.com
PTC Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PTC Inc. - PTC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of…
3 weeks ago zacks.com
Should You Buy PTC Inc. (PTC) After Golden Cross?
From a technical perspective, PTC Inc. (PTC) is looking like an interesting pick, as it just reached a key level of support. PTC's 50-day simple moving average crossed above its 200-day simple moving…
3 weeks ago benzinga.com
This Gentex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.
-
3 weeks ago benzinga.com
Mizuho Maintains Neutral on PTC, Raises Price Target to $205
Mizuho analyst Siti Panigrahi maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $160 to $205.
3 weeks ago benzinga.com
General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
Wall Street analysts raised targets for PTC, Cloudflare, PENN, Microsoft and others, while downgrading PTC and upgrading PENN and Abbott.
-
3 weeks ago benzinga.com
BMO Capital Downgrades PTC to Market Perform, Raises Price Target to $205
BMO Capital analyst Daniel Jester downgrades PTC (NASDAQ:PTC) from Outperform to Market Perform and raises the price target from $164 to $205.
3 weeks ago benzinga.com
Nasdaq Surges Over 1% as Market Sentiment Improves — CNN Fear & Greed Index Climbs to 43, But ‘Fear’ Still Dominates
U.S. stocks rose Monday, led by Nasdaq’s 1.05% gain, while CNN’s Fear & Greed Index improved to 43 but stayed in fear; PTC surged on $22.6B buyout.
3 weeks ago benzinga.com
Novavax, Nvidia, MercadoLibre, Nu Holdings and PTC: Why These 5 Stocks Are on Investors' Radars Today
NVAX, NVDA, MELI, NU, PTC were among the stocks seen trending on Monday, Oct. 5, 2026.
3 weeks ago benzinga.com
QUICK SPARK: Brazil's Retail Broker XP Notches Best Day Ever, Tops Russell 1000 Performers
XP Inc. jumped 34% to its best day ever, leading the Russell 1000 after Flávio Bolsonaro won the first round of Brazil's presidential vote.
3 weeks ago benzinga.com
12 Information Technology Stocks Moving In Monday's Intraday Session
Gainers Veea (NASDAQ:VEEA) shares increased by 49.8% to $4.99 during Monday's regular session. The market value of their outstanding shares is at $10.3 million. Socket Mobile (NASDAQ:SCKT) stock rose…
-
3 weeks ago benzinga.com
RBC Capital Downgrades PTC to Sector Perform, Raises Price Target to $306
RBC Capital analyst Matthew Hedberg downgrades PTC (NASDAQ:PTC) from Outperform to Sector Perform and raises the price target from $195 to $306.
3 weeks ago benzinga.com
Nasdaq 100 Hits Record, Brazil's EWZ Soars 13%: Stock Market Today
Nasdaq 100 hits a record as Brazil's EWZ jumps 13% on Bolsonaro's election upset; ISM services prices hit a four-year high and the 10-year yield tops 5.3%.
3 weeks ago benzinga.com
RXO, Vaxcyte, PTC And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed as Dow falls 250+ points; RXO surges 23% on $5.8B C.H. Robinson deal, while Vaxcyte and PTC post major gains.
3 weeks ago benzinga.com
US Stocks Mixed; Nasdaq Gains Over 50 Points
U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.
3 weeks ago benzinga.com
Industrial AI Arms Race Heats up: Schneider Electric Buys PTC for $22.6 Billion
PTC stock jumps as Schneider Electric buys the industrial software firm for $22.6 billion ($205/share). Key deal terms & analysis here.
3 weeks ago benzinga.com
Why PTC Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
PTC jumped 34.7% after Schneider Electric offered $22.6B; Columbus Acquisition soared 657.5%, while Zeta Network Group fell 23.3% premarket.
-
3 weeks ago benzinga.com
Schneider Electric To Acquire PTC For $205 Per Share In All-Cash Deal Valuing Equity At $22.6B, Funded By Equity And Debt Issuance
Key HighlightsAll-cash acquisition at $205 per share for 100% of the share capital of PTC, valuing PTC’s equity at approximately $22.6 billion (€20.1 billion)Implied Enterprise Value of $23.7 billion…
-
3 months ago benzinga.com
Citigroup Maintains Neutral on PTC, Raises Price Target to $141
Citigroup analyst Tyler Radke maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $127 to $141.
-
3 months ago benzinga.com
Barclays Maintains Overweight on PTC, Raises Price Target to $155
Barclays analyst Saket Kalia maintains PTC (NASDAQ:PTC) with a Overweight and raises the price target from $150 to $155.
-
3 months ago benzinga.com
Piper Sandler Maintains Neutral on PTC, Lowers Price Target to $157
Piper Sandler analyst Clarke Jeffries maintains PTC (NASDAQ:PTC) with a Neutral and lowers the price target from $175 to $157.
-
3 months ago benzinga.com
PTC Sees Q4 Adj EPS $1.63-$2.21 vs $1.81 Est; Sees Sales $630.000M-$690.000M vs $649.518M Est
PTC (NASDAQ:PTC) is looking for Q4 Adj EPS of $1.63-$2.21 vs $1.81 analyst estimate. sees sales of $630.000 million-$690.000 million vs $649.518 million analyst estimate.
-
3 months ago benzinga.com
PTC Narrows FY2026 Adj EPS Guidance from $6.65-$8.90 to $7.87-$8.42 vs $7.83 Est; Raises FY2026 Sales Guidance from $2.580B-$2.820B to $2.690B-$3.750B vs $2.725B Est
PTC (NASDAQ:PTC) narrows FY2026 Adj EPS guidance from $6.65-$8.90 to $7.87-$8.42 vs $7.83 analyst estimate. Raises FY2026 sales outlook from $2.580 billion-$2.820 billion to $2.690 billion-$3.750…
-
3 months ago benzinga.com
PTC Q3 Adj. EPS $1.58 Beats $1.57 Estimate, Sales $600.049M Miss $608.056M Estimate
PTC (NASDAQ:PTC) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.57 by 0.64 percent. This is a 3.66 percent decrease over earnings of $1.64 per share…
-
3 months ago benzinga.com
Barclays Maintains Overweight on PTC, Lowers Price Target to $150
Barclays analyst Saket Kalia maintains PTC (NASDAQ:PTC) with a Overweight and lowers the price target from $185 to $150.
-
4 months ago benzinga.com
BNP Paribas Initiates Coverage On PTC with Neutral Rating, Announces Price Target of $130
BNP Paribas analyst Andrew DeGasperi initiates coverage on PTC (NASDAQ:PTC) with a Neutral rating and announces Price Target of $130.
4 months ago benzinga.com
Chips Lead Nasdaq 100 Rebound, Oracle Sinks 11%: Stock Market Today
The S&P 500 gained 0.5% while the tech-heavy Nasdaq 100 rose 1.1% by midday Thursday, extending a rebound from one-month lows.
-
5 months ago benzinga.com
PTC Named Official Engine Design Software Partner Of TRD U.S.A.
PTC named Official Engine Design Software Partner of TRDCreo CAD and Windchill PLM are designated solutions for design and development of TRD's high-performance enginesCreo CAD and Windchill PLM…
-
5 months ago benzinga.com
Citigroup Maintains Neutral on PTC, Raises Price Target to $155
Citigroup analyst Tyler Radke maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $146 to $155.